Company Information
- Type:
- Company
- Country:
- Mexico
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 08 July 2021 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 30 June 2024
Parent Company
| Country | Company Name |
|---|---|
| United Kingdom | AstraZeneca UK Ltd |
Communication On Progress
| Published On | Title | Level |
|---|---|---|
| 2022-06-02 | Communication on Progress AstraZeneca 2021 | Advanced |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.
Parent Communication On Progress
| Published On | Title | Level |
|---|---|---|
| 2022-07-18 | 2022 Communication on Progress | Not applicable |
| 2022-06-27 | Communication on Progress | Advanced |
| 2021-03-31 | Communication on Progress 2020 | Advanced |
| 2020-04-03 | Communication on Progress | Advanced |
| 2019-04-04 | Communication on Progress AstraZeneca 2019 | Advanced |
| 2018-04-23 | Communication on Progress | Advanced |
| 2017-04-29 | Communication on Progress | Active |
| 2016-06-06 | Communication on Progress AstraZeneca 2016 | Active |
| 2015-06-10 | AstraZeneca Communication on Progress 2015 | Learner |
| 2015-03-06 | Grace Letter | Not applicable |
| 2014-03-28 | Communication on Progress 2014 | Advanced |
| 2013-03-28 | AstraZeneca 2012 | Advanced |
| 2012-03-28 | 2011 Communication on Progress | Advanced |
| 2011-04-08 | 2010 Communication on Progress | Advanced |
| 2010-12-21 | Grace Letter | Not applicable |